The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
- 1 January 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 15 (1) , 3-10
Abstract
The 6-minute-walk test is a commonly used assessment of performance ability in a variety of cardiopulmonary diseases. It provides important functional information that is not captured in standardized pulmonary function testing. The test may be influenced by factors other than the severity of lung disease, including frailty, deconditioning, and musculoskeletal issues. The primary output measure from the 6-minute-walk test is the distance walked, which appears to confer prognostic information in many diverse disease states. The 6-minute-walk test distance has served as a primary endpoint in many drug trials, most notably in the field of pulmonary arterial hypertension, and to a lesser extent in idiopathic pulmonary fibrosis (IPF). Although the 6-minute-walk test has been used in clinical practice and research trials of IPF, there are no specific guidelines regarding its implementation in this growing patient population. Given that there is increasing evidence and experience with its use in clinical trials, development of nuanced standards designed specifically for IPF are much needed. This review touches on a number of complex and crucial issues in the application of this test and provides a framework for future development of 6-minute-walk test guidelines customized for IPF.Keywords
This publication has 40 references indexed in Scilit:
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumoniaRespiratory Research, 2014
- An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory diseaseEuropean Respiratory Journal, 2014
- An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory diseaseEuropean Respiratory Journal, 2014
- Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial PneumoniaChest, 2014
- Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New MillenniumChest, 2011
- Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosisRespiratory Medicine, 2009
- Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The 6-min Walk Test*Chest, 2003
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002